Page last updated: 2024-08-26

artesunic acid and Brain Neoplasms

artesunic acid has been researched along with Brain Neoplasms in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (75.00)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Chai, T; Du, Q; Hanif, S; Ismail, M; Li, Y; Muhammad, P; Shi, B; Yang, W; Zhang, D; Zheng, M1
Chen, T; Chen, Z; Liu, L; Liu, Y; Nie, Y; Ouyang, Q; Wei, S; Yin, W; Zeng, F1
Efferth, T; Giordano, FA; Krishna, S; Schmiedek, P; Schöttler, U; Wenz, F1
Halatsch, ME; Karpel-Massler, G; Kast, RE1
Bai, Y; Dong, J; Du, Z; Guo, G; Hu, X; Huang, X; Jia, J; Lian, S; Ma, N; Shi, R; Song, B; Wang, M; Yang, B; Zhang, Y1
Berte, N; Eich, M; Kaina, B; Kim, E; Lokan, S1
Lee, TY; Lu, H; Sheng, R; Zhang, C1
Efferth, T; Hehlgans, S; Reichert, S; Reinboldt, V; Rödel, C; Rödel, F1

Other Studies

8 other study(ies) available for artesunic acid and Brain Neoplasms

ArticleYear
Targeted liposomes for combined delivery of artesunate and temozolomide to resistant glioblastoma.
    Biomaterials, 2022, Volume: 287

    Topics: Animals; Antineoplastic Agents, Alkylating; Apolipoproteins E; Artesunate; Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Glioblastoma; Liposomes; Mice; Temozolomide; Xenograft Model Antitumor Assays

2022
Artesunate inhibits the mevalonate pathway and promotes glioma cell senescence.
    Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:1

    Topics: Artesunate; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Proliferation; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Glioma; Humans; Hydroxymethylglutaryl CoA Reductases; Metabolic Networks and Pathways; Mevalonic Acid; Models, Biological; Protein Binding; Protein Transport; Sterol Regulatory Element Binding Protein 2; Transcription, Genetic; Tumor Suppressor Protein p53

2020
Answer to the comment of Hai Lu et al. regarding "Hepatotoxicity by combination treatment of temozolomide, artesunate and Chinese herbs in a glioblastoma multiforme patient: case report and review of the literature. Arch Toxicol (2016)".
    Archives of toxicology, 2017, Volume: 91, Issue:6

    Topics: Artemisinins; Artesunate; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Dacarbazine; Glioblastoma; Humans; Temozolomide

2017
CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.
    Oncotarget, 2014, Sep-30, Volume: 5, Issue:18

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Artemisinins; Artesunate; Auranofin; Brain Neoplasms; Captopril; Celecoxib; Dacarbazine; Disulfiram; Glioblastoma; Humans; Itraconazole; Molecular Targeted Therapy; Morpholines; Neoplasm Recurrence, Local; Pyrazoles; Ritonavir; Sertraline; Signal Transduction; Sulfonamides; Temozolomide; Treatment Outcome

2014
Artesunate attenuates glioma proliferation, migration and invasion by affecting cellular mechanical properties.
    Oncology reports, 2016, Volume: 36, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Artemisinins; Artesunate; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Claudin-1; Gene Expression Regulation, Neoplastic; Glioma; Humans; Neoplasm Invasiveness; RNA, Small Interfering; Signal Transduction; Up-Regulation

2016
Artesunate enhances the therapeutic response of glioma cells to temozolomide by inhibition of homologous recombination and senescence.
    Oncotarget, 2016, Oct-11, Volume: 7, Issue:41

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Artemisinins; Artesunate; Brain Neoplasms; Cell Death; Cellular Senescence; Dacarbazine; Glioma; Homologous Recombination; Humans; Mice; Mice, Nude; Temozolomide; Xenograft Model Antitumor Assays

2016
Comments regarding "Hepatotoxicity by combination treatment of temozolomide, artesunate and Chinese herbs in a glioblastoma multiforme patient: case report review of the literature".
    Archives of toxicology, 2017, Volume: 91, Issue:6

    Topics: Artemisinins; Artesunate; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Dacarbazine; Glioblastoma; Humans; Temozolomide

2017
A radiosensitizing effect of artesunate in glioblastoma cells is associated with a diminished expression of the inhibitor of apoptosis protein survivin.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2012, Volume: 103, Issue:3

    Topics: Apoptosis; Artemisinins; Artesunate; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; DNA Repair; Dose-Response Relationship, Drug; Down-Regulation; Glioblastoma; Humans; Inhibitor of Apoptosis Proteins; Neoplasm Proteins; Radiation-Sensitizing Agents; Survivin

2012